← Archive
IN FORCE Import policy & restrictions ·?

143 Special condition under which the permission for import of drug with residual shelf life less than 60% is allowed 2020-Dec-18 983 KB

Reliability

In force — no superseding record on file.

Document text

File No. DCGI/Misc/2020 (110) Government of India Directorate General of Health Services Central Drugs Standard Control Organization (DCGI Secretariat)

FDA Bhawan, Kotla Road New Delhi-110002 pee’ 1 9 Okt Ue

Circular

Subject: Special Condition under which the permission for import of drug with residual shelf life less than 60% is allowed.

In light of representation received and Covid-19 pandemic situation, the effective date of the circular of even no. dated 17.04.2020 and 10.07.2020 issued on subject cited above is extended up to 30" April 2021 or till further order whichever is earlier.

\te pes (Dr. V. G. Somani) Drugs Controller General (India)

;

To:

All port offices of CDSCO.

Copy to: All Zonal Sub-zonal offices of CDSCO.

Copy for information to: PS to JS (R), Ministry of Health & Family Welfare, Nirman Bhawan, New Delhi.

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 24555 --apply.

Citation copied